Antibody Engineering

The YUMAB® platform can be used for the engineering of already existing antibodies that were generated externally. Two in-vitro evolution technologies are available for the optimization of the antibody’s affinity, stability, specificity or selectivity:

  • in-vitro evolution by YUlight shuffling
  • in-vitro evolution by mutagenesis

Additionally, in-silico analysis can be applied to identify and optimize antibodies with the best developability score.

  • in-silico analysis and optimization

Contact

YUMAB GMBH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany

Email: info@yumab.com
Phone: +49 531 481170-0